St James Hospital, Dublin, Ireland
Ther Adv Neurol Disord. 2009 Jul;2(4):241-60. doi: 10.1177/1756285609103483.
Alzheimer's disease (AD) and vascular dementia (VaD) are important causes of cognitive decline in the elderly. As a result of an ageing population worldwide, the incidence of dementia is expected to rise exponentially over the coming decades. Vascular risk factors are implicated in the pathogenesis of both AD and VaD. Hypertension in midlife is particularly associated with an increased risk of developing dementia. One might hope the treatment of high blood pressure in midlife would reduce the risk of developing dementia, as it does the risk of stroke. Divergent results have been reported in studies examining this effect, with the evidence suggesting that certain antihypertensives confer benefits beyond others. This implies that certain drugs may have neuroprotective properties separate to their blood pressure lowering capabilities. Recent trials have added to our understanding of these relationships.
阿尔茨海默病(AD)和血管性痴呆(VaD)是老年人认知能力下降的重要原因。由于全球人口老龄化,预计在未来几十年,痴呆症的发病率将呈指数级增长。血管危险因素与 AD 和 VaD 的发病机制有关。中年时期的高血压尤其与痴呆风险增加有关。人们可能希望中年时期高血压的治疗能够降低患痴呆症的风险,就像降低中风风险一样。在研究这种效果的研究中,报告了不同的结果,有证据表明某些降压药的益处超过其他降压药。这意味着某些药物可能具有独立于降压能力之外的神经保护特性。最近的试验增加了我们对这些关系的理解。